Vimarsana
Biggest News Aggregation in the World

Accelerated Approval Pathway News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accelerated Approval Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accelerated Approval Pathway Today - Breaking & Trending Today

To save lives, the FDA must change how it evaluates rare disease treatments - Vimarsana News

To save lives, the FDA must change how it evaluates rare disease treatments

For some conditions, few approved treatments exist. Without accelerated approval, the FDA is failing patients

Source: yahoo.com
FDA approves world's first vaccine for 'emerging global health threat': 'Prevention of a potentially debilitating disease' - Vimarsana News

FDA approves world's first vaccine for 'emerging global health threat': 'Prevention of a potentially debilitating disease'

Valneva said it hopes to commercialize the vaccine in the U.S. early next year.

Source: yahoo.com
FDA eyes efficacy of $900K cancer drug - Vimarsana News

FDA eyes efficacy of $900K cancer drug

FDA panel urges Acrotech Biopharma to accelerate research into two blood cancer drugs approved via the FDA's accelerated approval pathway.

Schrader registers to lobby - Vimarsana News

Schrader registers to lobby

The Oregon Democrat lost his bid for reelection last year and is now a principal at Williams and Jensen, which represents a number of pharmaceutical clients.

Clinical Overview: Lecanemab Offers Hope for Patients With Alzheimer Disease - Vimarsana News

Clinical Overview: Lecanemab Offers Hope for Patients With Alzheimer Disease

Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody that targets amyloid plaques, which are thought to play a role in the development and progression of Alzheimer disease.